Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.759,05
2,33%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSX Neovasc Inc (NVCN) Neovasc Inc (NVCN) Notizie

NVCN

Neovasc (NVCN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NVCN
DataOraFonteTitoloSimboloCompagnia
17/01/202314:21PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - NVCNTSX:NVCNNeovasc Inc
17/01/202314:15PR Newswire (Canada)IIROC Trade Resumption - NVCNTSX:NVCNNeovasc Inc
17/01/202314:11PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - NVCNTSX:NVCNNeovasc Inc
17/01/202314:09PR Newswire (Canada)IIROC Trading Halt - NVCNTSX:NVCNNeovasc Inc
30/09/201914:55PR Newswire (US)Neovasc's Tiara™ for Treatment of Mitral Regurgitation and Neovasc Reducer™ for Treatment of Refractory Angina Featured i...TSX:NVCNNeovasc Inc
23/09/201914:55PR Newswire (US)Tiara™ for Treatment of Mitral Regurgitation and Neovasc Reducer™ for Treatment of Refractory Angina to be Featured at TC...TSX:NVCNNeovasc Inc
16/09/201914:55PR Newswire (US)Neovasc Announces Changes to its Board of DirectorsTSX:NVCNNeovasc Inc
04/09/201914:55PR Newswire (US)Neovasc to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceTSX:NVCNNeovasc Inc
03/09/201914:55PR Newswire (US)The European Society of Cardiology Includes Neovasc Reducer™ for the Treatment of Refractory Angina in the European Practic...TSX:NVCNNeovasc Inc
22/08/201914:55PR Newswire (US)Neovasc Receives Nasdaq Notification Regarding Minimum Market Value DeficiencyTSX:NVCNNeovasc Inc
07/08/201922:01PR Newswire (US)Neovasc Announces Second Quarter 2019 Financial ResultsTSX:NVCNNeovasc Inc
05/08/201914:55PR Newswire (US)Neovasc to Attend Canaccord Genuity 39th Annual Growth ConferenceTSX:NVCNNeovasc Inc
02/08/201914:55PR Newswire (US)Neovasc to Announce Second Quarter 2019 Financial Results on Wednesday, August 7thTSX:NVCNNeovasc Inc
17/07/201921:04PR Newswire (US)Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq DeficiencyTSX:NVCNNeovasc Inc
16/07/201914:55PR Newswire (US)Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory AnginaTSX:NVCNNeovasc Inc
15/07/201922:11PR Newswire (US)Neovasc Participates in Round-Robin Study Evaluating In-Vitro Pulsatile Flow Testing of Prosthetic Heart ValvesTSX:NVCNNeovasc Inc
12/07/201914:55PR Newswire (Canada)Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDATSX:NVCNNeovasc Inc
28/06/201913:00PR Newswire (US)Neovasc Announces Effective Date of Share ConsolidationTSX:NVCNNeovasc Inc
27/06/201914:55PR Newswire (US)Neovasc Announces Presentations on Tiara™ for Treatment of Mitral Regurgitation and Reducer™ for Treatment of Refractory ...TSX:NVCNNeovasc Inc
25/06/201920:30PR Newswire (US)Neovasc Regains Compliance with Nasdaq Minimum Market Value RuleTSX:NVCNNeovasc Inc
17/06/201914:55PR Newswire (US)Tiara™ Featured in Presentation at 11th Annual TVT 2019TSX:NVCNNeovasc Inc
07/06/201919:30PR Newswire (US)Neovasc Announces Nasdaq Continuing to Monitor Minimum Market Value Deficiency Following 10 Consecutive Business Days Above U...TSX:NVCNNeovasc Inc
04/06/201920:15PR Newswire (US)Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders and Provides Update on Neovasc Reducer™TSX:NVCNNeovasc Inc
28/05/201914:55PR Newswire (US)Neovasc Announces Publication of Peer-Reviewed Article in European Heart Journal Concluding Positive Cost-Effectiveness of th...TSX:NVCNNeovasc Inc
23/05/201915:17PR Newswire (US)New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in ParisTSX:NVCNNeovasc Inc
22/05/201923:32PR Newswire (US)Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article ...TSX:NVCNNeovasc Inc
17/05/201902:00PR Newswire (US)Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 MillionTSX:NVCNNeovasc Inc
14/05/201913:00PR Newswire (Canada)Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 MillionTSX:NVCNNeovasc Inc
10/05/201903:58PR Newswire (US)/C O R R E C T I O N from Source -- Neovasc Inc./TSX:NVCNNeovasc Inc
09/05/201922:00PR Newswire (Canada)Neovasc Announces First Quarter 2019 Financial ResultsTSX:NVCNNeovasc Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSX:NVCN

La tua Cronologia

LSE
TXP
Touchstone Exploration
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network